Teva Not Responsible for Hepatitis Outbreak, Lawyer Says
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd., the world’s biggest generic-drug maker, isn’t responsible for a 2008 hepatitis outbreak in Nevada blamed on the misuse of vials of the anesthetic propofol, a lawyer for the company said.
Patients developed hepatitis C after receiving propofol during colonoscopies, Mark Tully, a lawyer for Teva, told jurors today in a trial of three lawsuits against the company. Doctors and medical personnel who performed the procedures are to blame, he said in opening statements.